Patents by Inventor Hwan-Myung LEE

Hwan-Myung LEE has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Composition comprising erigeron annuus flower essential oil for prevention and treatment of neuromuscular disease
    Patent number: 11224564
    Abstract: Disclosed are a pharmaceutical composition and a beauty-purposed pharmaceutical composition for prevention or treatment of neuromuscular disease, the composition including a combination of Erigeron annuus flower-based essential oil and Botox. Erigeron annuus flower-based essential oil inhibits t-SNARE protein and v-SNARE protein expression in neurons to inhibit the formation of SNARE protein complexes. Erigeron annuus flower-based essential oil inhibits the regeneration of t-SNARE protein and v-SNARE protein degraded by Botox to inhibit neurotransmitter release. Accordingly, an efficacy duration of Botox may be extended. Thus, Erigeron annuus flower-based essential oil may be usefully used in combination with Botox as Botox adjuvant for the prevention and treatment of neuromuscular disease or for beauty.
    Type: Grant
    Filed: September 11, 2018
    Date of Patent: January 18, 2022
    Assignee: HOSEO UNIVERSITY ACADEMIC COOPERATION FOUNDATION
    Inventors: Hwan-Myung Lee, Dae-Il Hwang, Do-Yoon Kim, Soo-Min Park, Ha-Bin Kim
  • COMPOSITION COMPRISING ERIGERON ANNUUS FLOWER ESSENTIAL OIL FOR PREVENTION AND TREATMENT OF NEUROMUSCULAR DISEASE
    Publication number: 20210085588
    Abstract: Disclosed are a pharmaceutical composition and a beauty-purposed pharmaceutical composition for prevention or treatment of neuromuscular disease, the composition including a combination of Erigeron annuus flower-based essential oil and Botox. Erigeron annuus flower-based essential oil inhibits t-SNARE protein and v-SNARE protein expression in neurons to inhibit the formation of SNARE protein complexes. Erigeron annuus flower-based essential oil inhibits the regeneration of t-SNARE protein and v-SNARE protein degraded by Botox to inhibit neurotransmitter release. Accordingly, an efficacy duration of Botox may be extended. Thus, Erigeron annuus flower-based essential oil may be usefully used in combination with Botox as Botox adjuvant for the prevention and treatment of neuromuscular disease or for beauty.
    Type: Application
    Filed: September 11, 2018
    Publication date: March 25, 2021
    Applicant: HOSEO UNIVERSITY ACADEMIC COOPERATION FOUNDATION
    Inventors: Hwan-Myung LEE, Dae-ll HWANG, Do-Yoon KIM, Soo-Min PARK, Ha-Bin KIM